InMode Ltd. Stock Plummets to New 52-Week Low at $12.95

NodeGuardian

2026-03-12 14:53:04

Abstract generation in progress

InMode Ltd., a small-cap Pharmaceuticals & Biotechnology company, has plunged to a new 52-week low of $12.95, marking a 28.66% stock price drop over the past year. This decline follows five consecutive quarters of negative results, including a 67.35% fall in net profit and low operating cash flow. The company’s financial performance significantly underperforms the S&P 500, highlighting challenges in its financial landscape.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.